Tag:
MicroPhage
Latest Headlines
Latest Headlines
MicroPhage, Cardinal Health ink deal on MRSA test
Longmont, CO-based MicroPhage has reached an agreement granting Cardinal Health exclusive rights to market the KeyPath MRSA/MSSA blood culture test product line in North America. Under this
FDA clears MicroPhage's test for drug-resistant Staph
Longmont, CO-based MicroPhage has received 510(k) clearance from the FDA to market its KeyPath MRSA/MSSA blood culture test--BT, which returns same-day antibiotic susceptibility results for
